367 related articles for article (PubMed ID: 11249755)
1. Biophysical targeting of adenovirus vectors for gene therapy.
Silman NJ; Fooks AR
Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
[TBL] [Abstract][Full Text] [Related]
2. Targeting adenovirus.
Wickham TJ
Gene Ther; 2000 Jan; 7(2):110-4. PubMed ID: 10673715
[TBL] [Abstract][Full Text] [Related]
3. Generation and selection of targeted adenoviruses embodying optimized vector properties.
Noureddini SC; Krendelshchikov A; Simonenko V; Hedley SJ; Douglas JT; Curiel DT; Korokhov N
Virus Res; 2006 Mar; 116(1-2):185-95. PubMed ID: 16293334
[TBL] [Abstract][Full Text] [Related]
4. Targeting of adenoviral vectors through a bispecific single-chain antibody.
Haisma HJ; Grill J; Curiel DT; Hoogeland S; van Beusechem VW; Pinedo HM; Gerritsen WR
Cancer Gene Ther; 2000 Jun; 7(6):901-4. PubMed ID: 10880021
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus dodecahedron, a new vector for human gene transfer.
Fender P; Ruigrok RW; Gout E; Buffet S; Chroboczek J
Nat Biotechnol; 1997 Jan; 15(1):52-6. PubMed ID: 9035106
[TBL] [Abstract][Full Text] [Related]
6. Fiber-modified adenoviruses for targeted gene therapy.
Wu H; Curiel DT
Methods Mol Biol; 2008; 434():113-32. PubMed ID: 18470642
[TBL] [Abstract][Full Text] [Related]
7. A system for the propagation of adenoviral vectors with genetically modified receptor specificities.
Douglas JT; Miller CR; Kim M; Dmitriev I; Mikheeva G; Krasnykh V; Curiel DT
Nat Biotechnol; 1999 May; 17(5):470-5. PubMed ID: 10331807
[TBL] [Abstract][Full Text] [Related]
8. Genetic targeting strategies for adenovirus.
Noureddini SC; Curiel DT
Mol Pharm; 2005; 2(5):341-7. PubMed ID: 16196486
[TBL] [Abstract][Full Text] [Related]
9. Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand.
Hoganson DK; Sosnowski BA; Pierce GF; Doukas J
Mol Ther; 2001 Jan; 3(1):105-12. PubMed ID: 11162317
[TBL] [Abstract][Full Text] [Related]
10. Recombinant adenovirus vectors with knobless fibers for targeted gene transfer.
van Beusechem VW; van Rijswijk AL; van Es HH; Haisma HJ; Pinedo HM; Gerritsen WR
Gene Ther; 2000 Nov; 7(22):1940-6. PubMed ID: 11127582
[TBL] [Abstract][Full Text] [Related]
11. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.
Mizuguchi H; Koizumi N; Hosono T; Utoguchi N; Watanabe Y; Kay MA; Hayakawa T
Gene Ther; 2001 May; 8(9):730-5. PubMed ID: 11406768
[TBL] [Abstract][Full Text] [Related]
12. Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob.
Miura Y; Yoshida K; Nishimoto T; Hatanaka K; Ohnami S; Asaka M; Douglas JT; Curiel DT; Yoshida T; Aoki K
Gene Ther; 2007 Oct; 14(20):1448-60. PubMed ID: 17700705
[TBL] [Abstract][Full Text] [Related]
13. Re-targeted adenovirus vectors with dual specificity; binding specificities conferred by two different Affibody molecules in the fiber.
Myhre S; Henning P; Friedman M; Ståhl S; Lindholm L; Magnusson MK
Gene Ther; 2009 Feb; 16(2):252-61. PubMed ID: 18946496
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell targeted gene delivery by adenovirus 5 vectors carrying knobless fibers with antibody-binding domains.
Henning P; Andersson KM; Frykholm K; Ali A; Magnusson MK; Nygren PA; Granio O; Hong SS; Boulanger P; Lindholm L
Gene Ther; 2005 Feb; 12(3):211-24. PubMed ID: 15510176
[TBL] [Abstract][Full Text] [Related]
15. Fiber-mosaic adenovirus as a novel approach to design genetically modified adenoviral vectors.
Pereboeva L; Komarova S; Mahasreshti PJ; Curiel DT
Virus Res; 2004 Sep; 105(1):35-46. PubMed ID: 15325079
[TBL] [Abstract][Full Text] [Related]
16. Genetic targeting of adenovirus vectors using a reovirus sigma1-based attachment protein.
Schagen FH; Wensveen FM; Carette JE; Dermody TS; Gerritsen WR; van Beusechem VW
Mol Ther; 2006 May; 13(5):997-1005. PubMed ID: 16515889
[TBL] [Abstract][Full Text] [Related]
17. Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism.
Leissner P; Legrand V; Schlesinger Y; Hadji DA; van Raaij M; Cusack S; Pavirani A; Mehtali M
Gene Ther; 2001 Jan; 8(1):49-57. PubMed ID: 11402301
[TBL] [Abstract][Full Text] [Related]
18. Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells.
McDonald D; Stockwin L; Matzow T; Blair Zajdel ME; Blair GE
Gene Ther; 1999 Sep; 6(9):1512-9. PubMed ID: 10490760
[TBL] [Abstract][Full Text] [Related]
19. Novel adenoviral gene delivery system targeted against head and neck cancer.
Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
[TBL] [Abstract][Full Text] [Related]
20. Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins.
Medina-Kauwe LK; Maguire M; Kasahara N; Kedes L
Gene Ther; 2001 Dec; 8(23):1753-61. PubMed ID: 11803394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
